PRKN and Parkinson disease: If confirmed by future work, this redox chemistry-based expansion of parkin functions in the ageing human midbrain (Supplementary Fig. 10, online resource) may open the door to testing its anti-oxidant role in related neurodegenerative conditions, such as late-onset, non-PRKN-linked PD [13].